Treatment for Early Stages of Renal Cell Carcinoma | Judy Nicholson Kidney Cancer Foundation
Presented by the Judy Nicholson Kidney Cancer Foundation and moderated by Joel Stern, a stage IV warrior advocate, this open forum panel discusses stages 1-3 renal cell carcinoma and patient care strategies. The panel included Dr. Brittany Cotta - Urologic oncologist specializing in surgical treatment of cancers of the genitourinary (GU) system, Dr. Chad Tang - Radiation oncologist at MD Anderson Cancer Center, Dr. Pavlos Msaouel - Physician-scientist focused on kidney cancer research, particularly rare subtypes like renal medullary carcinoma, and Dr. Abdelsalam - Interventional radiologist specializing in minimally invasive therapies for kidney and liver cancers. Dr. Cotta discussed surgical options for stages 1 through 3 renal cell carcinoma (RCC), including partial nephrectomy, radical nephrectomy, and active surveillance based on tumor size, location, and patient factors. Dr. Tang spoke about non-surgical options like radiation therapy, emphasizing advancements in precision techniques for localized kidney cancers and the role of radiation in oligometastatic and oligo-progressive disease. Dr. Msaouel discussed the importance of genetic testing (germline vs. somatic mutations), biomarkers, and personalized approaches to treatment. Dr. Abdelsalam elaborated on ablation techniques (freezing vs. heating), their pros and cons, and their role in treating small renal masses. Key points discussed in this video include Surgical Options, Biopsies, Adjuvant Therapy, Genetic Testing, Imaging, Clinical Trials, Probiotics and Diet, Tumor Boards, and Advocacy. The session emphasized hope, progress in treatment options, and the importance of collaboration between patients, caregivers, and medical professionals. The Judy Nicholson Kidney Cancer Foundation is dedicated to providing support and education for kidney cancer patients and caregivers. For more info visit: www.jfnkidneycancer.org
